![]() |
產地 | 進口、國產 |
品牌 | 上海莼試 |
保存條件 | Store at -20 °C |
貨號 | CS9852 |
應用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS編號 | |
抗體名 | Anti-Phospho-NF2(Ser518) |
克隆性 | |
靶點 | 詳見說明書 |
適應物種 | 詳見說明書 |
形態(tài) | 詳見說明書 |
宿主 | 詳見說明書 |
亞型 | IgG |
標識物 | 詳見說明書 |
濃度 | 1mg/1ml% |
免疫原 | KLH conjugated Synthesised phosphopeptide derived from human Merlin around the phosphorylation site of Ser518 |
抗體的生物素化標記實驗要點:
1. 磷酸化2型神經抗體說明書 如在反應混合液中有疊氮鈉或游離氨基存在,會抑制標記反應。因此,蛋白質在反應前要對 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;
2.所用的NHSB及待生物素化蛋白質之間的分子比按蛋白質表面的ε-氨基的密度會有所不同,選擇不當則影響標記的效率,應先用幾個不同的分子比來篩選最適條件;
3.用NHSB量過量也是不利的,抗原的結合位點可能因此被封閉,導致抗體失活;
4.由于抗體的氨基不易接近可能造成生物素化不足,此時可加入去污劑如 Triton x-100, Tween20等;
5.當游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結合位點時,或位于酶的催化位點時,生物素化會降低或損傷抗體蛋白的結合力或活性;
6.生物素還可能與不同的功能基團,如羰基、氨基、巰基、異咪唑基及*基,也可與糖基共價結合;
7.交聯反應后,應充分透析,否則,殘余的生物素會對生物素化抗體與親和素的結合產生競爭作用;
8.在細胞的熒光標記實驗中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對某些細胞可導致高本底。
產品訂購信息:
英文名稱 Anti-Phospho-NF2(Ser518)
中文名稱 磷酸化2型神經抗體說明書
別 名 Merlin(Phospho-Ser518); NF2(phospho S518); neurofibromatosis type 2; CAN; BANF; bilateral acoustic neuroma; moesin ezrin radixin like protein; Moesin ezrin radizin like protein; merlin; Neurofibromatosis 2; ACN; Bilateral acoustic neuroma; MERL_HUMAN; Merlin; Moesin ezrin radizin like; Moesin-ezrin-radixin-like protein; Neurofibromatosis type 2; Neurofibromin-2; NF 2; Nf2; Neurofibromatosis2; Neurofibromin 2; Neurofibromin2; Schwannomerlin; NF-2; SCH; Schwannomin.
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit
產品類型 一抗 磷酸化抗體
研究領域 細胞生物 免疫學 神經生物學 信號轉導 細胞凋亡 轉錄調節(jié)因子
蛋白分子量 predicted molecular weight: 70kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human Merlin around the phosphorylation site of Ser518
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化2型神經抗體說明書 產品應用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蠟切片需做抗原修復)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產品介紹 Neurofibromin 2 (NF2) is a tumor suppressor gene encoding the protein Merlin. Merlin is closely related to the ERM (ezrin, radixin, moesin) family of proteins. The precise funtion of Merlin is not clear. It is thought to provide a link between the actin cytoskeleten and membrane associated proteins, playing a role in transduction of extracellular signals. It has been implicated in cell proliferation and cellular motility. Mutations in the NF2 gene cause neurofibromatosis type II, a condition characterised by the development of tumors in the central nervous system.
Function : Probable regulator of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway, a signaling pathway that plays a pivotal role in tumor suppression by restricting proliferation and promoting apoptosis. Along with WWC1 can synergistically induce the phosphorylation of LATS1 and LATS2 and can probably function in the regulation of the Hippo/SWH (Sav/Wts/Hpo) signaling pathway. May act as a membrane stabilizing protein. May inhibit PI3 kinase by binding to AGAP2 and impairing its stimulating activity. Suppresses cell proliferation and tumorigenesis by inhibiting the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex.Subunit : Interacts with SLC9A3R1, HGS and AGAP2. Interacts with LAYN (By similarity). Interacts with SGSM3. Interacts (via FERM domain) with MPP1. Interacts with WWC1. Interacts with the CUL4A-RBX1-DDB1-VprBP/DCAF1 E3 ubiquitin-protein ligase complex. The unphosphorylated form interacts (via FERM domain) with VPRBP/DCAF1.Subcellular Location : Isoform 1: Cell projection, filopodium membrane; Peripheral membrane protein; Cytoplasmic side. Cell projection, ruffle membrane; Peripheral membrane protein; Cytoplasmic side. Nucleus. Note=In a fibroblastic cell line, isoform 1 is found homogeneously distributed over the entire cell, with a particularly strong staining in ruffling membranes and filopodia. Colocalizes with MPP1 in non-myelin-forming Schwann cells. Binds with VPRBP in the nucleus. The intramolecular association of the FERM domain with the C-terminal tail promotes nuclear accumulation. The unphosphorylated form accumulates predominantly in the nucleus while the phosphorylated form is largely confined to the non-nuclear fractions.Isoform 7: Cytoplasm, perinuclear region. Cytoplasmic granule. Note=Observed in cytoplasmic granules concentrated in a perinuclear location. Isoform 7 is absent from ruffling membranes and filopodia.Isoform 9: Cytoplasm, perinuclear region. Cytoplasmic granule. Note=Observed in cytoplasmic granules concentrated in a perinuclear location. Isoform 9 is absent from ruffling membranes and filopodia.Isoform 10: Nucleus. Cell projection, filopodium membrane; Peripheral membrane protein; Cytoplasmic side. Cell projection, ruffle membrane; Peripheral membrane protein; Cytoplasmic side. Cytoplasm, perinuclear region. Cytoplasmic granule. Cytoplasm, cytoskeleton. Note=In a fibroblastic cell line, isoform 10 is found homogeneously distributed over the entire cell, with a particularly strong staining in ruffling membranes and filopodia.Tissue Specificity : Widely expressed. Isoform 1 and isoform 3 are predominant. Isoform 4, isoform 5 and isoform 6 are expressed moderately. Isoform 8 is found at low frequency. Isoform 7, isoform 9 and isoform 10 are not expressed in adult tissues, with the exception of adult retina expressing isoform 10. Isoform 9 is faintly expressed in fetal brain, heart, lung, skeletal muscle and spleen. Fetal thymus expresses isoforms 1, 7, 9 and 10 at similar levels.Post-translational modifications : Phosphorylation of Ser-518 inhibits nuclear localization by disrupting the intramolecular association of the FERM domain with the C-terminal tail.Ubiquitinated by the CUL4A-RBX1-DDB1-DCAF1/VprBP E3 ubiquitin-protein ligase complex for ubiquitination and subsequent proteasome-dependent degradation.DISEASE : Neurofibromatosis 2 (NF2) [MIM:101000]: Genetic disorder characterized by bilateral vestibular schwannomas (formerly called acoustic neuromas), schwannomas of other cranial and peripheral nerves, meningiomas, and ependymomas. It is inherited in an autosomal dominant fashion with full penetrance. Affected individuals generally develop symptoms of eighth-nerve dysfunction in early adulthood, including deafness and balance disorder. Although the tumors of NF2 are histologically benign, their anatomic location makes management difficult, and patients suffer great morbidity and mortality. Note=The disease is caused by mutations affecting the gene represented in this entry.Schwannomatosis (SCHWA) [MIM:162091]: Schwannomas are benign tumors of the peripheral nerve sheath that usually occur singly in otherwise normal individuals. Multiple schwannomas in the same individual suggest an underlying tumor-predisposition syndrome. The most common such syndrome is NF2. The hallmark of NF2 is the development of bilateral vestibular-nerve schwannomas; but two-thirds or more of all NF2-affected individuals develop schwannomas in other locations, and dermal schwannomas may precede vestibular tumors in NF2-affected children. There have been several reports of individuals with multiple schwannomas who do not show evidence of vestibular schwannoma. Clinical report suggests that schwannomatosis is a clinical entity distinct from other forms of neurofibromatosis. Note=The disease is caused by mutations affecting the gene represented in this entry.Mesothelioma, malignant (MESOM) [MIM:156240]: An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. Note=The disease may be caused by mutations affecting the gene represented in this entry.Similarity : Contains 1 FERM domain.Database links : UniProtKB/Swiss-Prot: P35240.1Ⅱ型神經(neurofibromatosisⅡ,NF2)又稱merlin蛋白在細胞與細胞的信號傳遞中起著關鍵作用,可能與其它類型也有關聯。
抗體的鑒定:
1)磷酸化2型神經抗體說明書 抗體的效價鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價。不同的抗原制備的抗體,要求的效價不一。鑒定效價的方法很多,包括有試管凝集反應,瓊脂擴散試驗,酶聯免疫吸附試驗等。常用的抗原所制備的抗體一般都有約成的鑒定效價的方法,以資比較。如制備抗抗體的效價,一般就采用瓊脂擴散試驗來鑒定。
2)抗體的特異性鑒定:抗體的特異性是指與相應抗原或近似抗原物質的識別能力??贵w的特異性高,它的識別能力就強。衡量特異性通常以交叉反應率來表示。交叉反應率可用競爭抑制試驗測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計算各自的結合率,求出各自在IC50時的濃度,并按公式計算交叉反應率。
如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質的IC50濃度幾乎是無窮大時,表示這一抗血清與其他抗原物質的交叉反應率近似為0,即該血清的特異性較好。
3)抗體親和力:是指抗體和抗原結合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結合位點與抗原決定簇之間立體構型的合適度決定的。有助于維持抗原抗體復合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數K表示,K的單位是L/mol??贵w親和力的測定對抗體的篩選,確定抗體的用途,驗證抗體的均一性等均有重要意義。
CD4(Rabbit Anti-Human Mouse rat CD4 Palyclonal Anti-body) CD4抗原Multi-class antibodies規(guī)格: 0.5mg
Anti-Phospho-HP1 gamma (Ser83) 磷酸化染色質相關蛋白1-γ抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh PCDHB15/PCDHB22 原鈣粘蛋白15抗體 規(guī)格 0.2ml
IL17RA Kit Human 人 IL17RA / CD217 ELISA配對抗體 ELISA
THRA1+2 英文名稱: 甲狀腺激素受體α1+α2抗體 0.2ml
Collagen I 英文名稱: Ⅰ型膠原抗體 0.1ml
Anti-Phospho-HP1 gamma (Ser83) 磷酸化染色質相關蛋白1-γ抗體Multi-class antibodies規(guī)格: 0.1ml
DHEA(Mouse Dehydroepiandrosterone) ELISA Kit 小鼠脫氫表雄酮Multi-class antibodies規(guī)格: 48T
Anti-CD226/DNAM-1/FITC 熒光素標記CD226抗體IgGMulti-class antibodies規(guī)格: 0.2ml
Rhesus antibody Rh Donkey Anti-human IgG/Alexa Fluor 488 Alexa Fluor 488標記的驢抗人IgG 規(guī)格 0.1ml
AMPK ELISA Kit 魚磷酸化腺苷酸活化蛋白激酶 96T
MLF1 英文名稱: 髓細胞性蛋白1抗體 0.2ml
ADAM17 英文名稱: 壞死因子α轉換酶 0.1ml
Anti-CD226/DNAM-1/FITC 熒光素標記CD226抗體IgGMulti-class antibodies規(guī)格: 0.2ml
HSP-27(Human heat shock protein 27) ELISA Kit 人熱休克蛋白27Multi-class antibodies規(guī)格: 48T
Anti-P73 protein P73抑制基因抗體Multi-class antibodies規(guī)格: 0.1ml
Rhesus antibody Rh HSD17B1 羥類固醇脫氫酶17β-HSD抗體 規(guī)格 0.1ml
ATG(Human anti-thymocyte globulin) ELISA Kit 人抗胸腺細胞球蛋白 96T
PDCD2L 英文名稱: 程序性細胞死亡2樣抗體 0.2ml
CKAP1 英文名稱: 細胞骨架相關蛋白1/微管蛋白折疊輔助因子B抗體 0.2ml
Anti-P73 protein P73抑制基因抗體Multi-class antibodies規(guī)格: 0.1ml
肉膏酵母葡萄糖瓊脂250g用于厭氧菌培養(yǎng)
Fluid A incubation media Fluid A
島青霉 能防治煙草赤星病,對陽性細菌、大腸桿菌、白色假絲酵母無作用。 支/瓶
ColumbiaBloodAgar
CornMeatMedium
改良CCD瓊脂基礎(mCCD)250g用于彎曲桿菌的分離培養(yǎng)(GB標準)
李斯特氏菌顯色培養(yǎng)基 Listera Chromogenic Medium 用于李斯特氏菌的顯色培養(yǎng),單增李斯特氏菌顯藍色,外圍有一不透明環(huán)
LPM瓊脂 LPM Agar 250 用于單增李氏菌選擇性分離(加入七葉苷和檸檬酸鐵銨)(FDA標準)
3%氯堿性蛋白胨水250g/瓶用于副溶血性弧菌選擇性增菌incubationmedia3%氯堿性蛋白胨水250g/瓶用于副溶血性弧菌選擇性增菌
DoubleLactoseBileFermen
磷酸化2型神經抗體說明書 菊糖 規(guī)格: 20支/盒 用途: 細菌生化鑒定
蕈糖 規(guī)格: 20支/盒 用途: 細菌生化鑒定
粘液酸鹽質控肉湯 規(guī)格: 20支/盒 用途: 細菌生化鑒定
粘液酸鹽測試肉湯 規(guī)格: 20支/盒 用途: 細菌生化鑒定